Helena Mörse

617 total citations
19 papers, 312 citations indexed

About

Helena Mörse is a scholar working on Public Health, Environmental and Occupational Health, Reproductive Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Helena Mörse has authored 19 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 6 papers in Reproductive Medicine and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Helena Mörse's work include Childhood Cancer Survivors' Quality of Life (5 papers), Reproductive Biology and Fertility (5 papers) and Ovarian function and disorders (5 papers). Helena Mörse is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (5 papers), Reproductive Biology and Fertility (5 papers) and Ovarian function and disorders (5 papers). Helena Mörse collaborates with scholars based in Sweden, United States and Denmark. Helena Mörse's co-authors include Thoas Fioretos, Ingrid Øra, Bertil Johansson, Kajsa Paulsson, Mikael Behrendtz, Bodil Strömbeck, Felix Mitelman, Claus Yding Andersen, Björn Nilsson and Magnus Fontes and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

In The Last Decade

Helena Mörse

18 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helena Mörse Sweden 10 169 83 76 65 61 19 312
Hasan Acar Türkiye 12 62 0.4× 88 1.1× 26 0.3× 57 0.9× 74 1.2× 33 315
Katayoon Shirneshan Germany 10 79 0.5× 118 1.4× 82 1.1× 26 0.4× 15 0.2× 21 271
U. Sancken Germany 10 96 0.6× 99 1.2× 77 1.0× 112 1.7× 94 1.5× 18 368
Mei-Tsz Su Taiwan 13 109 0.6× 92 1.1× 51 0.7× 123 1.9× 100 1.6× 21 482
Siobhan Rice United Kingdom 6 64 0.4× 106 1.3× 60 0.8× 39 0.6× 13 0.2× 11 230
Lihong Pang China 12 56 0.3× 101 1.2× 21 0.3× 51 0.8× 85 1.4× 36 376
Xunqiang Yin China 9 101 0.6× 126 1.5× 25 0.3× 78 1.2× 129 2.1× 16 362
Bum‐Chae Choi South Korea 11 119 0.7× 63 0.8× 20 0.3× 119 1.8× 35 0.6× 20 332
Sung Eun Hur South Korea 11 147 0.9× 73 0.9× 15 0.2× 324 5.0× 18 0.3× 17 554
Johanna Prast Austria 7 47 0.3× 91 1.1× 16 0.2× 70 1.1× 91 1.5× 7 328

Countries citing papers authored by Helena Mörse

Since Specialization
Citations

This map shows the geographic impact of Helena Mörse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Mörse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Mörse more than expected).

Fields of papers citing papers by Helena Mörse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Mörse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Mörse. The network helps show where Helena Mörse may publish in the future.

Co-authorship network of co-authors of Helena Mörse

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Mörse. A scholar is included among the top collaborators of Helena Mörse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Mörse. Helena Mörse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Bontell, Thomas Olsson, Tomas Sjöberg Bexelius, Jonas A. Nilsson, et al.. (2024). A pilocytic astrocytoma with novel ATG16L1::NTRK2 fusion responsive to larotrectinib: a case report with genomic and functional analysis. The Oncologist. 30(3).
2.
Mörse, Helena, et al.. (2024). Anti-Müllerian hormone and fertility in women after childhood cancer treatment: Association with current infertility risk classifications. PLoS ONE. 19(8). e0308827–e0308827. 3 indexed citations
4.
Jaffe, Eli, et al.. (2022). Real-time video communication between ambulance paramedic and scene – a simulation-based study. BMC Health Services Research. 22(1). 1049–1049. 4 indexed citations
5.
Leijonhufvud, Irene, et al.. (2021). Quality of life among female childhood cancer survivors with and without premature ovarian insufficiency. Journal of Cancer Survivorship. 17(1). 101–109. 8 indexed citations
6.
Mörse, Helena, et al.. (2021). Premature ovarian failure after childhood cancer and risk of metabolic syndrome: a cross-sectional analysis. European Journal of Endocrinology. 185(1). 67–75. 8 indexed citations
7.
Mörse, Helena, et al.. (2018). Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment. Acta Oncologica. 58(2). 218–224. 22 indexed citations
8.
Mörse, Helena, et al.. (2016). Severe gonadotoxic insult manifests early in young girls treated for Ewing sarcoma. Medicine. 95(33). e4512–e4512. 4 indexed citations
9.
Mörse, Helena & Ingrid Øra. (2016). Reliability of AMH in Serum after Long-term Storage at -80°C and an Extended Thawing Episode. Research at the University of Copenhagen (University of Copenhagen). 4(1). 16 indexed citations
10.
Mörse, Helena, et al.. (2012). Acute onset of ovarian dysfunction in young females after start of cancer treatment. Pediatric Blood & Cancer. 60(4). 676–681. 31 indexed citations
11.
Arnbjörnsson, Einar, et al.. (2006). Complications of video-assisted gastrostomy in children with malignancies or neurological diseases. Acta Paediatrica. 95(4). 467–470. 5 indexed citations
12.
Paulsson, Kajsa, Markus Heidenblad, Helena Mörse, et al.. (2006). Identification of cryptic aberrations and characterization of translocation breakpoints using array CGH in high hyperdiploid childhood acute lymphoblastic leukemia. Leukemia. 20(11). 2002–2007. 27 indexed citations
13.
Arnbjörnsson, Einar, et al.. (2006). Complications of video‐assisted gastrostomy in children with malignancies or neurological diseases. Acta Paediatrica. 95(4). 467–470. 10 indexed citations
14.
Andersson, Anna, Tor Olofsson, David Lindgren, et al.. (2005). Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations. Proceedings of the National Academy of Sciences. 102(52). 19069–19074. 78 indexed citations
15.
Paulsson, Kajsa, Helena Mörse, Thoas Fioretos, et al.. (2005). Evidence for a single‐step mechanism in the origin of hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes and Cancer. 44(2). 113–122. 51 indexed citations
16.
Panagopoulos, Ioannis, et al.. (2004). MLL/GRAF fusion in an infant acute monocytic leukemia (AML M5b) with a cytogenetically cryptic ins(5;11)(q31;q23q23). Genes Chromosomes and Cancer. 41(4). 400–404. 12 indexed citations
17.
Paulsson, Kajsa, Helena Mörse, Thoas Fioretos, et al.. (2004). Evidence for a Single Step Mechanism in the Origin of Hyperdiploid Childhood Acute Lymphoblastic Leukemia.. Blood. 104(11). 1966–1966. 4 indexed citations
18.
Sveger, Tomas, K. Ohlsson, Helena Mörse, Staffan Polberger, & S. Laurin. (2003). Plasma neutrophil lipocalin, elastase‐α 1 ‐antitrypsin complex and neutrophil protease 4 in preterm infants with respiratory distress syndrome. Scandinavian Journal of Clinical and Laboratory Investigation. 63(2). 89–92. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026